- Home
- ZLAB vs ZI Comparison
ZLAB vs ZI Comparison
Compare ZLAB & ZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- ZI
- Stock Information
- Founded
- ZLAB 2013
- ZI 2007
- Country
- ZLAB China
- ZI United States
- Employees
- ZLAB N/A
- ZI N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- ZI Computer Software: Prepackaged Software
- Sector
- ZLAB Health Care
- ZI Technology
- Exchange
- ZLAB Nasdaq
- ZI Nasdaq
- Market Cap
- ZLAB 3.4B
- ZI 3.9B
- IPO Year
- ZLAB 2017
- ZI 2020
- Fundamental
- Price
- ZLAB $36.14
- ZI $10.50
- Analyst Decision
- ZLAB Buy
- ZI Hold
- Analyst Count
- ZLAB 3
- ZI 21
- Target Price
- ZLAB $47.37
- ZI $11.79
- AVG Volume (30 Days)
- ZLAB 1.3M
- ZI 8.6M
- Earning Date
- ZLAB 05-07-2025
- ZI 05-06-2025
- Dividend Yield
- ZLAB N/A
- ZI N/A
- EPS Growth
- ZLAB N/A
- ZI N/A
- EPS
- ZLAB N/A
- ZI 0.08
- Revenue
- ZLAB $398,988,000.00
- ZI $1,214,300,000.00
- Revenue This Year
- ZLAB $45.57
- ZI $1.29
- Revenue Next Year
- ZLAB $47.91
- ZI $3.66
- P/E Ratio
- ZLAB N/A
- ZI $131.19
- Revenue Growth
- ZLAB 49.59
- ZI N/A
- 52 Week Low
- ZLAB $13.48
- ZI $7.65
- 52 Week High
- ZLAB $37.99
- ZI $16.98
- Technical
- Relative Strength Index (RSI)
- ZLAB 64.46
- ZI 45.46
- Support Level
- ZLAB $34.32
- ZI $11.18
- Resistance Level
- ZLAB $37.99
- ZI $11.93
- Average True Range (ATR)
- ZLAB 1.98
- ZI 0.56
- MACD
- ZLAB 0.02
- ZI -0.07
- Stochastic Oscillator
- ZLAB 72.51
- ZI 34.56
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About ZI ZoomInfo Technologies Inc
ZoomInfo Technologies Inc provides a go-to-market intelligence platform for sales and marketing teams. Its cloud-based go-to-market data and insights platform deliver comprehensive and high-quality intelligence and analytics to provide sales and marketing professionals with accurate information and insights on the organizations and professionals. Nearly all of its revenue is derived from the United States.